Hepatitis C News

Researchers found high rates of sexually transmitted hepatitis C among HIV-negative men who have sex with men who used pre-exposure prophylaxis, especially among drug users, according to data published in Journal of Hepatology.

The donor pool for heart transplants can potentially be expanded now that the infection from donor-derived hepatitis C is curable and well tolerated, according to a study published in JAMA Cardiology.

Data from a large, real-world study contributed to the growing safety and efficacy evidence of transplanting hepatitis C-infected organs into aviremic patients in the direct-acting antiviral era.

Patients with current or prior hepatitis C infection were willing to engage in alcohol intervention including counseling and referral to treatment when encouraged by liver medical providers, according to data published in Hepatology.

Patients who failed to achieve sustained virologic response after initial treatment for hepatitis C achieved high cure rates during retreatment after switching from an NS5A inhibitor direct-acting antiviral to a protease inhibitor.

ORLANDO — African Americans with lymphoma and hepatitis C virus should be treated for both disease states to improve response to lymphoma treatment, with most improved results seen in patients with aggressive lymphoma, according to a poster presenter at the ASH Annual Meeting and Exposition.

This year’s The Liver Meeting provided many exciting updates for viral hepatitis care ranging from steps toward eliminating hepatitis C to improving hepatitis B treatment options through data on hepatitis D.

Trio Health presented results from four studies at The Liver Meeting 2019 that showed novel outcomes in patients treated for hepatitis B with Vemlidy or hepatitis C with Vosevi.

The FDA approved changes to the product labels for direct-acting antivirals Harvoni, Epclusa, and Vosevi to include new efficacy and safety data for adults with hepatitis C and severe renal impairment, including those who require dialysis.

BOSTON — The Hepatitis C Leaders in Primary Care program, or HELP-C, engaged primary care physicians to successfully screen and treat veterans with hepatitis C through comanagement with a specialist liver team, according to a study presented at The Liver Meeting 2019.